跳至主要内容
临床试验/NCT05734235
NCT05734235已完成1 期

Ultraviolet B Radiation-Induced Microvesicle Particle Release in Human Skin

Wright State University2 个研究点 分布在 1 个国家目标入组 8 人开始时间: 2018年7月16日最近更新:
适应症

试验速览

阶段
1 期
状态
已完成
入组人数
8
试验地点
2
主要终点
Change in microvesicle particles (MVP) levels from baseline

研究概览

简要总结

This study is designed to assess if ultraviolet B radiation (UVB) found in sunlight causes the release of microvesicle particles in human skin, and if antioxidant vitamins can block their production.

研究设计

研究类型
Interventional
分配方式
Na
干预模型
Single Group
主要目的
Treatment
盲法
None

入排标准

年龄范围
21 Years 至 45 Years(Adult)
性别
Male
接受健康志愿者

入选标准

  • Male subjects
  • Ages 21 to 45
  • Skin type: Fitzpatrick Type I or II

排除标准

  • Have underlying diseases that could affect wound healing
  • On medications that are known photosensitizers (e.g., doxycycline) or anti-inflammatories (e.g., NSAIDS [except for low-dose aspirin] or steroids)
  • History of abnormal scarring (e.g., keloids)
  • Should not be on Vitamin C or E supplements for past month
  • Unable to understand/complete informed consent
  • Large volar arm tattoos that would inhibit the ability to conduct/evaluate the skin testing
  • Renal compromise/kidney stones or allergy to Vitamin C/Vitamin E or lidocaine anaesthetic
  • Use of tanning bends or recent UVB exposure to the areas in the past 3 months
  • Recent (within 1 week) use to sunscreen to volar forearms

结局指标

主要结局

Change in microvesicle particles (MVP) levels from baseline

时间窗: Day 8

Levels of microvesicle particles will be determined from skin biopsies

次要结局

未报告次要终点

研究者

申办方类型
Other
责任方
Sponsor

研究点 (2)

Loading locations...

相似试验

UVB-Induced MVP Release in Human Skin | 临床试验